Status:

COMPLETED

Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People

Lead Sponsor:

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborating Sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

HIV Infections

Eligibility:

All Genders

13+ years

Brief Summary

Early identification of tuberculosis (TB) is of particular importance in HIV-infected individuals, as a delay of therapy can be devastating in those with compromised immune systems. Diagnosis of TB in...

Detailed Description

Early diagnosis of tuberculosis (TB) is of particular importance in HIV-infected individuals, as a delay of therapy can be devastating in those with compromised immune systems. Diagnosis of TB in HIV ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • HIV-1 infection, as documented at any time prior to study entry by a rapid HIV test or any licensed ELISA test kit
  • Probable or confirmed pulmonary TB at the time of enrollment
  • Current use of an anti-TB regimen for treatment of active TB for fewer than 7 days prior to sputum sample collection or anticipated initiation of same within 30 days after study entry
  • Ability and willingness of participant or legal guardian/representative to provide informed consent.
  • Exclusion Criteria
  • Receipt of 7 or more cumulative days of anti-TB treatment within 12 months prior to sputum collection
  • Inability to provide sputum sample

Exclusion

    Key Trial Info

    Start Date :

    August 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2012

    Estimated Enrollment :

    641 Patients enrolled

    Trial Details

    Trial ID

    NCT00959088

    Start Date

    August 1 2009

    End Date

    June 1 2012

    Last Update

    April 11 2013

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Instituto de Pesquisa Clinica Evandro Chagas (12101)

    Rio de Janeiro, Brazil, 21045

    2

    Asociacion Civil Impacta Salud y Educacion - Miraf CRS (11301)

    Lima, Peru, 18 PE

    3

    Wits HIV CRS

    Johannesburg, Gauteng, South Africa

    Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People | DecenTrialz